-+ 0.00%
-+ 0.00%
-+ 0.00%

Serina Therapeutics Q4 EPS $(0.31) Beats $(0.46) Estimate

Benzinga·03/25/2026 20:37:20
Listen to the news
Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.46) by 32.61 percent. This is a 29.17 percent decrease over losses of $(0.24) per share from the same period last year.